85. Idiopathic interstitial pneumonia Clinical trials / Disease details
Clinical trials : 627 / Drugs : 443 - (DrugBank : 120) / Drug target genes : 99 - Drug target pathways : 212
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04677426 (ClinicalTrials.gov) | May 1, 2022 | 16/12/2020 | 129Xe Gas Exchange Imaging in IPF and cHP: A Reliability Study | 129Xe Gas Exchange Imaging in IPF and cHP: A Reliability Study | Idiopathic Pulmonary Fibrosis;Hypersensitivity Pneumonitis | Drug: Hyperpolarized Xe129 | University of Kansas Medical Center | Duke University;Children's Hospital Medical Center, Cincinnati;Boehringer Ingelheim | Withdrawn | 18 Years | N/A | All | 0 | Phase 2 | NULL |